Taiwan FDA granted the API Market License of Fulvestrant "GBC"
Taiwan FDA granted the in-house developed Generic Oncology (Cytotoxic) Active Pharmaceutical Ingredient Market License of Fulvestrant "GBC", Registration Number: MOHW-PM060990 (DMF No. : DMF(00)3629)
